A Dual Concentration-Tailored Cytokine-Chemo Nanosystem to Alleviate Multidrug Resistance and Redirect Balance of Cancer Proliferation and Apoptosis

Yu Hsia,1,2 Maharajan Sivasubramanian,1 Chia-Hui Chu,1 Yao-Chen Chuang,1,3 Yiu-Kay Lai,2 Leu-Wei Lo1 1Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan, Taiwan; 2Institute of Biotechnology, National Tsing Hua University, Hsinchu, Taiwan; 3Department of...

Full description

Bibliographic Details
Main Authors: Hsia Y, Sivasubramanian M, Chu CH, Chuang YC, Lai YK, Lo LW
Format: Article
Language:English
Published: Dove Medical Press 2023-07-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/a-dual-concentration-tailored-cytokine-chemo-nanosystem-to-alleviate-m-peer-reviewed-fulltext-article-IJN
_version_ 1797769087330287616
author Hsia Y
Sivasubramanian M
Chu CH
Chuang YC
Lai YK
Lo LW
author_facet Hsia Y
Sivasubramanian M
Chu CH
Chuang YC
Lai YK
Lo LW
author_sort Hsia Y
collection DOAJ
description Yu Hsia,1,2 Maharajan Sivasubramanian,1 Chia-Hui Chu,1 Yao-Chen Chuang,1,3 Yiu-Kay Lai,2 Leu-Wei Lo1 1Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan, Taiwan; 2Institute of Biotechnology, National Tsing Hua University, Hsinchu, Taiwan; 3Department of Radiation Oncology, Taipei Medical University Hospital, Taipei, TaiwanCorrespondence: Leu-Wei Lo, Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, 35, Keyan Road, Zhunan Town, Miaoli County 350, Zhunan, Taiwan, Tel +886-37-206-166 Ext 37115, Fax +886-37-586-440, Email lwlo@nhri.edu.tw Yiu-Kay Lai, Institute of Biotechnology, National Tsing Hua University, No. 101, Section 2, Kuang-Fu Road, Hsinchu, 300044, Taiwan, Tel +866-35-742-745, Email lslyk@life.nthu.edu.twBackground: Cancer multidrug resistance (MDR) is an important factor that severely affects the chemotherapeutic efficacy. Among various methods to bypass MDR, usage of cytokines, such as tumor necrosis factor alpha (TNFα) is attractive, which exerts antitumor effects of immunotherapeutic response and apoptotic/proinflammatory pathways. Nevertheless, the challenges remain how to implement targeted delivery of TNFα to reduce toxicity and manifest the involved signaling mechanism that subdues MDR.Methods: We synthesized a multifunctional nanosytem, in which TNFα covalently bound to doxorubicin (Dox)-loaded pH-responsive mesoporous silica nanoparticles (MSN) through bi-functional polyethylene glycol (TNFα-PEG-MSN-Hydrazone-Dox) as a robust design to overcome MDR.Results: The salient features of this nanoplatform are: 1) by judicious tailoring of TNFα concentration conjugated on MSN, we observed it could lead to a contrary effect of either proliferation or suppression of tumor growth; 2) the MSN-TNFα at higher concentration serves multiple functions, besides tumor targeting and inducer of apoptosis through extrinsic pathway, it inhibits the expression level of p-glycoprotein (P-gp), a cell membrane protein that functions as a drug efflux pump; 3) the enormous surface area of MSN provides for TNFα functionalization, and the nanochannels accommodate chemotherapeutics, Dox; 4) targeted intracellular release of Dox through the pH-dependent cleavage of hydrazone bonds induces apoptosis by the specific intrinsic pathway; and 5) TNFα-PEG-MSN-Hydrazone-Dox (MSN-Dox-TNFα) could infiltrate deep into the 3D spheroid tumor model through disintegration of tight junction proteins. When administered intratumorally in a Dox-resistant mouse tumor model, MSN-Dox-TNFα exhibited a synergistic therapeutic effect through the collective performances of TNFα and Dox.Conclusion: We hereby develop and demonstrate a multifunctional MSN-Dox-TNFα system with concentration-tailored TNFα that can abrogate the drug resistance mechanism, and significantly inhibit the tumor growth through both intrinsic and extrinsic apoptosis pathways, thus making it a highly potential nanomedicine translated in the treatment of MDR tumors.Graphical Abstract: Keywords: cytokine cancer therapy, tumor necrosis factor alpha, mesoporous silica nanoparticle, pH-responsive controlled release, intrinsic/extrinsic apoptosis pathways, cancer multidrug resistance
first_indexed 2024-03-12T21:03:48Z
format Article
id doaj.art-385a98cdb85048f185a7b76ac1d1922a
institution Directory Open Access Journal
issn 1178-2013
language English
last_indexed 2024-03-12T21:03:48Z
publishDate 2023-07-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj.art-385a98cdb85048f185a7b76ac1d1922a2023-07-30T19:00:26ZengDove Medical PressInternational Journal of Nanomedicine1178-20132023-07-01Volume 184253427485528A Dual Concentration-Tailored Cytokine-Chemo Nanosystem to Alleviate Multidrug Resistance and Redirect Balance of Cancer Proliferation and ApoptosisHsia YSivasubramanian MChu CHChuang YCLai YKLo LWYu Hsia,1,2 Maharajan Sivasubramanian,1 Chia-Hui Chu,1 Yao-Chen Chuang,1,3 Yiu-Kay Lai,2 Leu-Wei Lo1 1Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan, Taiwan; 2Institute of Biotechnology, National Tsing Hua University, Hsinchu, Taiwan; 3Department of Radiation Oncology, Taipei Medical University Hospital, Taipei, TaiwanCorrespondence: Leu-Wei Lo, Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, 35, Keyan Road, Zhunan Town, Miaoli County 350, Zhunan, Taiwan, Tel +886-37-206-166 Ext 37115, Fax +886-37-586-440, Email lwlo@nhri.edu.tw Yiu-Kay Lai, Institute of Biotechnology, National Tsing Hua University, No. 101, Section 2, Kuang-Fu Road, Hsinchu, 300044, Taiwan, Tel +866-35-742-745, Email lslyk@life.nthu.edu.twBackground: Cancer multidrug resistance (MDR) is an important factor that severely affects the chemotherapeutic efficacy. Among various methods to bypass MDR, usage of cytokines, such as tumor necrosis factor alpha (TNFα) is attractive, which exerts antitumor effects of immunotherapeutic response and apoptotic/proinflammatory pathways. Nevertheless, the challenges remain how to implement targeted delivery of TNFα to reduce toxicity and manifest the involved signaling mechanism that subdues MDR.Methods: We synthesized a multifunctional nanosytem, in which TNFα covalently bound to doxorubicin (Dox)-loaded pH-responsive mesoporous silica nanoparticles (MSN) through bi-functional polyethylene glycol (TNFα-PEG-MSN-Hydrazone-Dox) as a robust design to overcome MDR.Results: The salient features of this nanoplatform are: 1) by judicious tailoring of TNFα concentration conjugated on MSN, we observed it could lead to a contrary effect of either proliferation or suppression of tumor growth; 2) the MSN-TNFα at higher concentration serves multiple functions, besides tumor targeting and inducer of apoptosis through extrinsic pathway, it inhibits the expression level of p-glycoprotein (P-gp), a cell membrane protein that functions as a drug efflux pump; 3) the enormous surface area of MSN provides for TNFα functionalization, and the nanochannels accommodate chemotherapeutics, Dox; 4) targeted intracellular release of Dox through the pH-dependent cleavage of hydrazone bonds induces apoptosis by the specific intrinsic pathway; and 5) TNFα-PEG-MSN-Hydrazone-Dox (MSN-Dox-TNFα) could infiltrate deep into the 3D spheroid tumor model through disintegration of tight junction proteins. When administered intratumorally in a Dox-resistant mouse tumor model, MSN-Dox-TNFα exhibited a synergistic therapeutic effect through the collective performances of TNFα and Dox.Conclusion: We hereby develop and demonstrate a multifunctional MSN-Dox-TNFα system with concentration-tailored TNFα that can abrogate the drug resistance mechanism, and significantly inhibit the tumor growth through both intrinsic and extrinsic apoptosis pathways, thus making it a highly potential nanomedicine translated in the treatment of MDR tumors.Graphical Abstract: Keywords: cytokine cancer therapy, tumor necrosis factor alpha, mesoporous silica nanoparticle, pH-responsive controlled release, intrinsic/extrinsic apoptosis pathways, cancer multidrug resistancehttps://www.dovepress.com/a-dual-concentration-tailored-cytokine-chemo-nanosystem-to-alleviate-m-peer-reviewed-fulltext-article-IJNcytokine cancer therapytumor necrosis factor alphamesoporous silica nanoparticleph-responsive controlled releaseintrinsic/extrinsic apoptosis pathwayscancer multidrug resistance
spellingShingle Hsia Y
Sivasubramanian M
Chu CH
Chuang YC
Lai YK
Lo LW
A Dual Concentration-Tailored Cytokine-Chemo Nanosystem to Alleviate Multidrug Resistance and Redirect Balance of Cancer Proliferation and Apoptosis
International Journal of Nanomedicine
cytokine cancer therapy
tumor necrosis factor alpha
mesoporous silica nanoparticle
ph-responsive controlled release
intrinsic/extrinsic apoptosis pathways
cancer multidrug resistance
title A Dual Concentration-Tailored Cytokine-Chemo Nanosystem to Alleviate Multidrug Resistance and Redirect Balance of Cancer Proliferation and Apoptosis
title_full A Dual Concentration-Tailored Cytokine-Chemo Nanosystem to Alleviate Multidrug Resistance and Redirect Balance of Cancer Proliferation and Apoptosis
title_fullStr A Dual Concentration-Tailored Cytokine-Chemo Nanosystem to Alleviate Multidrug Resistance and Redirect Balance of Cancer Proliferation and Apoptosis
title_full_unstemmed A Dual Concentration-Tailored Cytokine-Chemo Nanosystem to Alleviate Multidrug Resistance and Redirect Balance of Cancer Proliferation and Apoptosis
title_short A Dual Concentration-Tailored Cytokine-Chemo Nanosystem to Alleviate Multidrug Resistance and Redirect Balance of Cancer Proliferation and Apoptosis
title_sort dual concentration tailored cytokine chemo nanosystem to alleviate multidrug resistance and redirect balance of cancer proliferation and apoptosis
topic cytokine cancer therapy
tumor necrosis factor alpha
mesoporous silica nanoparticle
ph-responsive controlled release
intrinsic/extrinsic apoptosis pathways
cancer multidrug resistance
url https://www.dovepress.com/a-dual-concentration-tailored-cytokine-chemo-nanosystem-to-alleviate-m-peer-reviewed-fulltext-article-IJN
work_keys_str_mv AT hsiay adualconcentrationtailoredcytokinechemonanosystemtoalleviatemultidrugresistanceandredirectbalanceofcancerproliferationandapoptosis
AT sivasubramanianm adualconcentrationtailoredcytokinechemonanosystemtoalleviatemultidrugresistanceandredirectbalanceofcancerproliferationandapoptosis
AT chuch adualconcentrationtailoredcytokinechemonanosystemtoalleviatemultidrugresistanceandredirectbalanceofcancerproliferationandapoptosis
AT chuangyc adualconcentrationtailoredcytokinechemonanosystemtoalleviatemultidrugresistanceandredirectbalanceofcancerproliferationandapoptosis
AT laiyk adualconcentrationtailoredcytokinechemonanosystemtoalleviatemultidrugresistanceandredirectbalanceofcancerproliferationandapoptosis
AT lolw adualconcentrationtailoredcytokinechemonanosystemtoalleviatemultidrugresistanceandredirectbalanceofcancerproliferationandapoptosis
AT hsiay dualconcentrationtailoredcytokinechemonanosystemtoalleviatemultidrugresistanceandredirectbalanceofcancerproliferationandapoptosis
AT sivasubramanianm dualconcentrationtailoredcytokinechemonanosystemtoalleviatemultidrugresistanceandredirectbalanceofcancerproliferationandapoptosis
AT chuch dualconcentrationtailoredcytokinechemonanosystemtoalleviatemultidrugresistanceandredirectbalanceofcancerproliferationandapoptosis
AT chuangyc dualconcentrationtailoredcytokinechemonanosystemtoalleviatemultidrugresistanceandredirectbalanceofcancerproliferationandapoptosis
AT laiyk dualconcentrationtailoredcytokinechemonanosystemtoalleviatemultidrugresistanceandredirectbalanceofcancerproliferationandapoptosis
AT lolw dualconcentrationtailoredcytokinechemonanosystemtoalleviatemultidrugresistanceandredirectbalanceofcancerproliferationandapoptosis